Labiotech.eu

News and Trends 14 Sep 2022

New study reveals first genetic links in ME and chronic fatigue syndrome

For the first time in more than 30 years, replicable genetic findings have been reported in the study into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). UK-based PrecisionLife today (September 14) unveiled the results offering new approaches for better diagnosis and treatments of patients. The data has also been submitted for peer reviewed publication and is available […]

September 14, 2022 - 3 minutesmins - By Liza Laws

News and Trends 13 Sep 2022

Results of phase 3 trial of injection for ovarian cancer imaging published

An injection for intraoperative imaging of folate receptor positive ovarian cancer can identify more of the disease than is unable to be identified conventionally. Biotech company On Target Laboratories announced that the results from its phase 3, 006 study of the Cytalux (pafolacianine) injection had been published in the Journal of Clinical Oncology yesterday (September […]

September 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 13 Sep 2022

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

WhiteLab Genomics has announced the completion of a $10 million funding round. The round was led by French venture capital firm Omnes Capital, and Debiopharm, a Switzerland based biopharmaceutical company with a venture arm focused on digital health. WhiteLab Genomics said it aims to “revolutionize genomic therapy development” using public and private data and in-house […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

New predictive biomarkers to be developed for larynx and hypopharynx carcinomas

A study to develop new, potential precision therapies in larynx and hypopharynx carcinomas has been announced today (September 13) by One Biosciences. The company was co-founded by Céline Vallot, Institut Curie and Home Biosciences, combining artificial intelligence (AI) and single-cell technologies to discover new therapeutic targets and develop novel precision medicines. The LARYCARE study, for […]

September 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 13 Sep 2022

Faron Pharmaceuticals’ Traumakine data shows promise for military applications

Faron Pharmaceuticals Ltd presented data from its preclinical salvage, preservation, and advanced resuscitation through endothelial stabilization (SPARES) study at the Military Health System Research Symposium (MHSRS) in Orlando, Florida, this week. The data was featured in the “Multi-Organ Dysfunction in Prolonged Field Care Scenarios” breakout session. The SPARES study was a preclinical study, conducted on […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

Ilya Pharma partners with US Defense Department for wound healing drug

A drug to accelerate wound healing and reduced scar volume has had a major breakthrough shown in results from a first in human trial. Ilya Pharma, a clinical stage immunotherapy company presented the findings at the US Defense Department’s (DoD) Military Health System Research Symposium (MHSRS) Conference in Florida and made the announcement yesterday (September […]

September 13, 2022 - 3 minutesmins - By Liza Laws

Optics11 Life receives €5 million in funding for drug development

News and Trends 13 Sep 2022

Arpeggio Biosciences raises $17M in Series A funding to support drug pipeline

Arpeggio Biosciences has raised $17 million in series A funding in a round led by Builders VC. Support for the U.S.-based preclinical therapeutics company making technology targeting transcriptional dysregulation in disease, also came from its seed round investors. These include Khosla Ventures, TechU Ventures, FundersClub, Alice Zhang, and Fifty Years, as well as new participants […]

September 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 13 Sep 2022

Starpharma announces new data for prostate cancer trial

Cabazitaxel (Jevtana, Sanofi) is a chemotherapy for the treatment of advanced prostate cancer (mCRPC). Developed by Australian biotech company Starpharma, DEP cabazitaxel is a patented, highly water soluble dendrimer nanoparticle version of standard cabazitaxel that has shown, in preclinical and clinical studies, benefits in terms of safety and efficacy. In a poster presentation at ESMO […]

September 13, 2022 - 2 minutesmins - By Jim Cornall

More News! 13 Sep 2022

Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment

Following its successful MedTech competition earlier this year, the UK’s largest kidney research charity, Kidney Research UK, has launched a new competition aimed at innovations in dialysis that will have a significant impact on patients’ lives. In collaboration with IN-PART’s Discover platform, this year’s competition will encourage scientists, academics, engineers and technology experts to propose […]

September 13, 2022 - 3 minutesmins - By External Contributor

News and Trends 13 Sep 2022

Himalaya Therapeutics publishes data on cancer treatment

Himalaya Therapeutics has given an interim topline data update from its phase 2 study of HTBA3011 (mecbotamab vedotin) in non-small cell lung cancer (NSCLC) and certain sarcomas. In August, Himalaya’s collaboration partner, BioAtla publicly announced operational updates on the ongoing global clinical trials for HTBA3011 in patients with AXL-positive NSCLC who have previously failed PD-1/L1, […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

Aldatu gets grant to develop Crimean Congo hemorrhagic fever test

U.S. biotech company Aldatu Biosciences has been awarded a $3 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The award will fund the advancement of the company’s proprietary PANDAA technology platform and its specific application to the […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

Scope Biosciences and WUR to improve CRISPR-Cas technology with new funds

Wageningen University & Research (WUR), and its spinoff Scope Biosciences, have received a grant of €150,000 ($152,000) from the European Research Council (ERC). The grant is to further research and enhance the diagnostic technology ScopeDx. This is based on CRISPR-Cas technology. Uniquely, this technology is able to quickly and accurately recognize viral or bacterial RNA. […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New study reveals first genetic links in ME and chronic fatigue syndrome

Results of phase 3 trial of injection for ovarian cancer imaging published

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

New predictive biomarkers to be developed for larynx and hypopharynx carcinomas

Faron Pharmaceuticals’ Traumakine data shows promise for military applications

Ilya Pharma partners with US Defense Department for wound healing drug

Arpeggio Biosciences raises $17M in Series A funding to support drug pipeline

Starpharma announces new data for prostate cancer trial

Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment

Himalaya Therapeutics publishes data on cancer treatment

Aldatu gets grant to develop Crimean Congo hemorrhagic fever test

Scope Biosciences and WUR to improve CRISPR-Cas technology with new funds

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!